i3 - January/February 2016 - 54

Qardio is the multi awardwinning healthcare company
that combines innovative
technologies, elegant design and powerful data analytics to
create the next generation of connected health. Our mission is
to revolutionize healthcare by creating medical devices with
an exceptional user experience and groundbreaking technical
innovation - a combination that's rare in the industry today.
Our clinically-validated, wearable and connected devices
seamlessly integrate with a smartphone or tablet using the
Qardio App - instantly turning them into a powerful doctor
in your pocket. The Qardio platform uses easy to understand
charts, stats and trends as well as smart feedback to provide
users with actionable insights into their heart health - making it
easy to monitor their own wellbeing and share their health data
with their family, friends or healthcare provider.
Reach Robotics is developing
the future of play with
MekaMon, the world's first
intelligent platform at the
intersection of robotics,
gaming and augmented reality.
MekaMon takes the form of an
upgradeable, four-legged, badass robot.
Evolving and learning over time, players can take control of
their MekaMon via smart phone or tablet and compete in the
real world against other players. They can also explore and
train in content rich augmented reality worlds where they battle
AI opponents in various game modes such as co-op and boss
battles.
ReliefBand is a wearable,
FDA cleared device for
the drug-free treatment of
nausea and vomiting associated with pregnancy and motion
sickness. The result of years of clinical research, ReliefBand's
patented technology uses accurately programmed pulses with
highly specific waveform, frequency and intensity to stimulate
the median nerve on the underside of the wrist. This precise
activity uses the body's natural neural pathways to block the
waves of nausea produced by the stomach. Safe and highly
effective, the technology behind ReliefBand has been used by
doctors and hospitals for the treatment of morning sickness
as well as post-operative nausea and sickness caused by
therapies such chemotherapy for nearly 20 years. This
technology has now been brought to a device that consumers
can buy over the counter for a MSRP of $89.99.

Remocam
At Remocam, we create smart
home and smart health devices.
We develop our software and
produce our own hardware.
We revolutionize the way
you care for your loved ones
with Remocam, RemoBell and
RemoPill.
We started with Remocam, a smart home security camera,
to monitor and control homes. Our patent-pending infrared
technology allows people to control their existing home
devices.
From there, we upgraded our security camera and expanded
our product line to our automated doorbell, RemoBell. Our next
product is a smart pill container, RemoPill. RemoPill won the
CES 2016 Innovation Awards Honoree.
Our engineers and management have decades of experience
inventing and creating products. We have the capacity to
expand our company beyond supplying existing IoT products, to
introducing new technology to consumers. We plan to continue
improving our products and releasing more smart home devices
in the near future.
RightEye
RightEye LLC is a health technology
company that uses eye tracking to
revolutionize vision performance
and patient care, improving how you see, how you feel and
how you perform. RightEye began shipping its first vision test
in October 2015. RightEye Neuro Vision is a first of its kind,
15-second concussion detection tool. At CES 2016, RightEye
will be unveiling RightEye Essential Vision, a two-minute,
comprehensive vision test that is expected to one day replace
standard vision screenings used around the world. Come visit
us at CES 2016 in booth #73944 and see what the future of vision
care looks like.
Roost
Founded in 2014 and based
in Sunnyvale, CA, Roost
delivers a simple, intuitive and affordable way for anyone to
enjoy smart home functionality through the easy retrofitting of
existing household products. The Roost Smart Battery solution
enables your smoke alarms to deliver important notifications to
your smartphone. Roost is the perfect choice for people looking
for the best ways to ensure the safety of their homes and loved
ones. Access to Roost's critical information instills a sense of
reassurance, security and empowerment.
The patented Roost Smart Battery uniquely combines a nonrechargeable lithium battery and advanced Wi-Fi in a familiar
9V package. Coupled with an intuitive smartphone app, the

54

JANUARY/FEBRUARY 2016

I T I S I N N O VAT I O N


https://www.getqardio.com/ https://remocam.com/ http://www.reachrobotics.com/ http://www.righteye.com/ http://www.reliefband.com/ http://www.getroost.com/

i3 - January/February 2016

Table of Contents for the Digital Edition of i3 - January/February 2016

Contents
i3 - January/February 2016 - Cover1
i3 - January/February 2016 - Cover2
i3 - January/February 2016 - Contents
i3 - January/February 2016 - 2
i3 - January/February 2016 - 3
i3 - January/February 2016 - 4
i3 - January/February 2016 - 5
i3 - January/February 2016 - 6
i3 - January/February 2016 - 7
i3 - January/February 2016 - 8
i3 - January/February 2016 - 9
i3 - January/February 2016 - 10
i3 - January/February 2016 - 11
i3 - January/February 2016 - 12
i3 - January/February 2016 - 13
i3 - January/February 2016 - 14
i3 - January/February 2016 - 15
i3 - January/February 2016 - 16
i3 - January/February 2016 - 17
i3 - January/February 2016 - 18
i3 - January/February 2016 - 19
i3 - January/February 2016 - 20
i3 - January/February 2016 - 21
i3 - January/February 2016 - 22
i3 - January/February 2016 - 23
i3 - January/February 2016 - 24
i3 - January/February 2016 - 25
i3 - January/February 2016 - 26
i3 - January/February 2016 - 27
i3 - January/February 2016 - 28
i3 - January/February 2016 - 29
i3 - January/February 2016 - 30
i3 - January/February 2016 - 31
i3 - January/February 2016 - 32
i3 - January/February 2016 - 33
i3 - January/February 2016 - 34
i3 - January/February 2016 - 35
i3 - January/February 2016 - 36
i3 - January/February 2016 - 37
i3 - January/February 2016 - 38
i3 - January/February 2016 - 39
i3 - January/February 2016 - 40
i3 - January/February 2016 - 41
i3 - January/February 2016 - 42
i3 - January/February 2016 - 43
i3 - January/February 2016 - 44
i3 - January/February 2016 - 45
i3 - January/February 2016 - 46
i3 - January/February 2016 - 47
i3 - January/February 2016 - 48
i3 - January/February 2016 - 49
i3 - January/February 2016 - 50
i3 - January/February 2016 - 51
i3 - January/February 2016 - 52
i3 - January/February 2016 - 53
i3 - January/February 2016 - 54
i3 - January/February 2016 - 55
i3 - January/February 2016 - 56
i3 - January/February 2016 - 57
i3 - January/February 2016 - 58
i3 - January/February 2016 - 59
i3 - January/February 2016 - 60
i3 - January/February 2016 - 61
i3 - January/February 2016 - 62
i3 - January/February 2016 - 63
i3 - January/February 2016 - 64
i3 - January/February 2016 - 65
i3 - January/February 2016 - 66
i3 - January/February 2016 - 67
i3 - January/February 2016 - 68
i3 - January/February 2016 - 69
i3 - January/February 2016 - 70
i3 - January/February 2016 - 71
i3 - January/February 2016 - 72
i3 - January/February 2016 - 73
i3 - January/February 2016 - 74
i3 - January/February 2016 - 75
i3 - January/February 2016 - 76
i3 - January/February 2016 - 77
i3 - January/February 2016 - 78
i3 - January/February 2016 - 79
i3 - January/February 2016 - 80
i3 - January/February 2016 - 81
i3 - January/February 2016 - 82
i3 - January/February 2016 - 83
i3 - January/February 2016 - 84
i3 - January/February 2016 - 85
i3 - January/February 2016 - 86
i3 - January/February 2016 - 87
i3 - January/February 2016 - 88
i3 - January/February 2016 - 89
i3 - January/February 2016 - 90
i3 - January/February 2016 - 91
i3 - January/February 2016 - 92
i3 - January/February 2016 - 93
i3 - January/February 2016 - 94
i3 - January/February 2016 - 95
i3 - January/February 2016 - 96
i3 - January/February 2016 - 97
i3 - January/February 2016 - 98
i3 - January/February 2016 - 99
i3 - January/February 2016 - 100
i3 - January/February 2016 - 101
i3 - January/February 2016 - 102
i3 - January/February 2016 - 103
i3 - January/February 2016 - 104
i3 - January/February 2016 - 105
i3 - January/February 2016 - 106
i3 - January/February 2016 - 107
i3 - January/February 2016 - 108
i3 - January/February 2016 - Cover3
i3 - January/February 2016 - Cover4
https://www.nxtbook.com/nxtbooks/manifest/i3_20210304
https://www.nxtbook.com/nxtbooks/manifest/i3_20210102
https://www.nxtbook.com/nxtbooks/manifest/i3_20201112
https://www.nxtbook.com/nxtbooks/manifest/i3_20200910
https://www.nxtbook.com/nxtbooks/manifest/i3_20200708
https://www.nxtbook.com/nxtbooks/manifest/i3_20200506
https://www.nxtbook.com/nxtbooks/manifest/i3_20200304
https://www.nxtbook.com/nxtbooks/manifest/i3_20200102
https://www.nxtbook.com/nxtbooks/manifest/i3_20191112
https://www.nxtbook.com/nxtbooks/manifest/i3_20190910
https://www.nxtbook.com/nxtbooks/manifest/i3_20190708
https://www.nxtbook.com/nxtbooks/manifest/i3_20190506
https://www.nxtbook.com/nxtbooks/manifest/i3_20190304
https://www.nxtbook.com/nxtbooks/manifest/i3_20190102
https://www.nxtbook.com/nxtbooks/manifest/i3_20181112
https://www.nxtbook.com/nxtbooks/manifest/i3_20180910
https://www.nxtbook.com/nxtbooks/manifest/i3_20180708
https://www.nxtbook.com/nxtbooks/manifest/i3_20180506
https://www.nxtbook.com/nxtbooks/manifest/i3_20180304
https://www.nxtbook.com/nxtbooks/manifest/i3_20180102
https://www.nxtbook.com/nxtbooks/manifest/i3_20171112
https://www.nxtbook.com/nxtbooks/manifest/i3_20170910
https://www.nxtbook.com/nxtbooks/manifest/i3_20170708
https://www.nxtbook.com/nxtbooks/manifest/i3_20160102
https://www.nxtbook.com/nxtbooks/manifest/i3_20160304
https://www.nxtbook.com/nxtbooks/manifest/i3_20160506
https://www.nxtbook.com/nxtbooks/manifest/i3_20160708
https://www.nxtbook.com/nxtbooks/manifest/i3_20170506
https://www.nxtbook.com/nxtbooks/manifest/i3_20170304
https://www.nxtbook.com/nxtbooks/manifest/i3_20170102
https://www.nxtbook.com/nxtbooks/manifest/i3_20161112
https://www.nxtbook.com/nxtbooks/manifest/i3_20160910
https://www.nxtbookmedia.com